Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.04. | Lirum Therapeutics, Inc.: Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting | 8 | GlobeNewswire (Europe) | New York, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (Lirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced... ► Artikel lesen | |
04.04. | NKT A/S: NKT invests in medium-voltage power cable business to boost capacity for growing demand | 60 | GlobeNewswire (Europe) | Investor news 4 April 2024 NKT invests in medium-voltage power cable business to boost capacity for growing demand To support growing demand from customers for medium-voltage power cables required... ► Artikel lesen | |
04.04. | HANetf Procure Space UCITS ETF: Merger into Future of Defence UCITS ETF | 201 | Business Wire | Notice of Result of an Extraordinary General Meeting of the Merging Fund
Dear Shareholder
We are writing to inform you that the following special resolution was passed at an Extraordinary General... ► Artikel lesen | |
04.04. | HANetf U.S. Global Jets UCITS ETF: Merger into The Travel UCITS ETF | 87 | Business Wire | Notice of Result of an Extraordinary General Meeting of the Merging Fund
Dear Shareholder
We are writing to inform you that the following special resolution was passed at an Extraordinary General... ► Artikel lesen | |
04.04. | International Paper: Further statement regarding possible offer for DS Smith plc | 27 | PR Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS... ► Artikel lesen | |
04.04. | Oncopeptides AB: Oncopeptides releases first quarter 2024 sales | 67 | GlobeNewswire (Europe) | Stockholm - April 4, 2024 - Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the unaudited net sales for the first quarter of 2024.
Oncopeptides... ► Artikel lesen | |
04.04. | Gorilla Technology Group Inc.: Gorilla Reports Record 2023 Financial Results | 133 | GlobeNewswire (Europe) | LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- -- 2023 revenues up 189% YoY compared to 2022, highlighting continued success globally ---- High value product and services business model reflected in 2023... ► Artikel lesen | |
04.04. | Exro Technologies Inc.: Exro Announces Shareholder Approval for Proposed Merger with SEA Electric | 163 | PR Newswire | CALGARY, AB, April 4, 2024 /CNW/ - Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro") is pleased to announce that all necessary shareholder and stockholder approvals required... ► Artikel lesen | |
04.04. | Olaplex Holdings, Inc.: OLAPLEX Announces CFO Transition | 583 | GlobeNewswire (Europe) | SANTA BARBARA, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or "the Company") today announced that Eric Tiziani will step down as Chief Financial Officer... ► Artikel lesen | |
04.04. | Teck Resources Ltd: Teck Provides Steelmaking Coal Sales and Pricing Update | 202 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) ("Teck") today provided unaudited first quarter 2024 steelmaking coal sales... ► Artikel lesen | |
04.04. | Semantix, Inc.: Semantix Announces Voluntary Delisting from the Nasdaq Global Market | 338 | GlobeNewswire (Europe) | SÃO PAULO, Brazil, April 04, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX) ("Semantix" or the "Company"), a leading Latin American enterprise AI platform and applications provider, announced... ► Artikel lesen | |
04.04. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 105 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
04.04. | Trisura Group Ltd: Trisura Group Announces Changes to its Board of Directors | 105 | GlobeNewswire (Europe) | TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Trisura Group Ltd. ("Trisura" or "Trisura Group") (TSX: TSU) today announced the appointment of Lilia Sham to its Board of Directors and the retirement... ► Artikel lesen | |
04.04. | Keyarch Acquisition Corp.: ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq on April 5, 2024, as the Business Combination between Keyarch Acquisition Corporation and ZOOZ Power Ltd. Has Been Completed | 114 | GlobeNewswire (Europe) | ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq under the Symbols "ZOOZ" and "ZOOZW," respectively NEW YORK, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Keyarch Acquisition Corporation... ► Artikel lesen | |
04.04. | GENFIT S.A.: GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update | 169 | GlobeNewswire (Europe) | Cash and cash equivalents totaled €77.8 million as of December 31, 2023Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 millionTopline interim data... ► Artikel lesen | |
04.04. | Amwell Receives Continued Listing Standard Notice From NYSE | 91 | GlobeNewswire (Europe) | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
04.04. | Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment | 138 | GlobeNewswire (Europe) | BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics... ► Artikel lesen | |
04.04. | Vimeo, Inc.: Vimeo Appoints Philip Moyer as New Chief Executive Officer | 153 | GlobeNewswire (Europe) | NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member... ► Artikel lesen | |
04.04. | Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 138 | GlobeNewswire (Europe) | WALTHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant... ► Artikel lesen | |
04.04. | Kura Sushi USA Announces Fiscal Second Quarter 2024 Financial Results | 298 | GlobeNewswire (Europe) | IRVINE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company") (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 3.974 |
EVOTEC | 3.346 |
TUI | 2.192 |
GAMESTOP | 2.060 |
NEL | 1.955 |
BAYER | 1.641 |
BYD | 1.521 |
RHEINMETALL | 1.346 |
SMA SOLAR | 1.309 |
CAVENDISH HYDROGEN | 1.177 |
DEUTSCHE LUFTHANSA | 1.166 |
AIXTRON SE | 989 |
TESLA | 975 |
SUPER MICRO COMPUTER | 898 |
VOLKSWAGEN | 797 |
THYSSENKRUPP | 721 |
PALANTIR TECHNOLOGIES | 696 |
DEFI TECHNOLOGIES | 686 |
APPLE | 654 |
BASF | 647 |
BIONTECH | 632 |
CARL ZEISS MEDITEC | 604 |
HEIDELBERGER DRUCK | 595 |
RENK GROUP | 591 |
DEUTSCHE BANK | 589 |